On this episode, I talk with Bob Garrett, CEO of Hackensack Meridian Health, based in New Jersey. Bob and I discuss the important role of hospitals and health systems in leading medical research and innovation to transform health care and make patient care better, accessible and more efficient.

Hackensack Meridian Health opened its Center for Discovery and Innovation in 2019. Preceding that, the heath system had a “robust” research infrastructure and a culture of innovation, Bob explains. “We encouraged innovation at the front lines of health care as well as through partnerships with our scientific community and with startup organizations.”

Even with the financial pressures facing the health care field, hospitals and health systems can support and sustain research and innovation in ways that aren’t costly and can provide community benefit right away, Bob observes. “Research can be done in population health and health equity that may not require a big capital commitment but can pay dividends in improving the overall health status of the communities we serve and in reducing some of the disparities we see — particularly in underserved areas as we look at health outcomes.”

I hope you find these conversations interesting and insightful. Look for them once a month as part of the Chair File.

Watch the episode below.


·

 

Related News Articles

Headline
In this recent episode of AHA’s Advancing Health podcast, Sara Robinson, senior associate healthcare architect at McMillan Pazdan Smith Architecture, and Jamie…
Chairperson's File
Public
Rural hospitals and health systems face big challenges, but together — with a unified voice — we can work to ensure people living in rural communities get the…
Chairperson's File
Trust — in one another, in our field, and in our communities — is so important to what we do. Everyone should know that our hospitals and health systems are a…
Perspective
Patient-centered care strategies and models that emphasize the importance of understanding and responding to patient preferences, needs and values. More care…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Chairperson's File
There is so much for health care leaders to navigate when it comes to public policy and government relations. Thankfully, the AHA has an expert team with…